Generation Bio Stock (NASDAQ: GBIO) stock price, news, charts, stock research, profile.
Open | $3.720 |
Close | $4.070 |
Volume / Avg. | 442.530K / 297.103K |
Day Range | 3.720 - 4.290 |
52 Wk Range | 0.860 - 6.980 |
Market Cap | $275.215M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 77 |
Short Interest | 3.25% |
Days to Cover | 3.89 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Generation Bio (NASDAQ: GBIO) through any online brokerage.
Other companies in Generation Bio’s space includes: bluebird bio (NASDAQ:BLUE), Atossa Therapeutics (NASDAQ:ATOS), FibroGen (NASDAQ:FGEN), Agenus (NASDAQ:AGEN) and Design Therapeutics (NASDAQ:DSGN).
The latest price target for Generation Bio (NASDAQ: GBIO) was reported by Wedbush on Thursday, March 7, 2024. The analyst firm set a price target for 5.00 expecting GBIO to rise to within 12 months (a possible 20.77% upside). 10 analyst firms have reported ratings in the last year.
The stock price for Generation Bio (NASDAQ: GBIO) is $4.14 last updated March 28, 2024 at 7:50 PM EDT.
There are no upcoming dividends for Generation Bio.
Generation Bio’s Q4 earnings are confirmed for Thursday, February 23, 2023.
There is no upcoming split for Generation Bio.
Generation Bio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.